TrialClinical therapeutics2009

Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers.

Ming-Yan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.